Ultraviolet Light Therapy for Systemic Lupus Erythematosus
| Status: | Recruiting |
|---|---|
| Conditions: | Lupus |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 15 - 70 |
| Updated: | 4/2/2016 |
| Start Date: | September 1991 |
OBJECTIVES:
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus
erythematosus and normal controls.
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus
erythematosus and normal controls.
PROTOCOL OUTLINE:
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the
lowest dose or frequency required to maintain a response. The dose and frequency are
progressively decreased over the next 9 weeks.
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the
lowest dose or frequency required to maintain a response. The dose and frequency are
progressively decreased over the next 9 weeks.
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American
Rheumatism Association criteria and normal controls
--Prior/Concurrent Therapy--
No requirement for tetracycline or other photosensitizing drugs
We found this trial at
2
sites
New Orleans, Louisiana 70112
Click here to add this to my saved trials
Click here to add this to my saved trials